{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:07:30Z","timestamp":1787508450444,"version":"build-2736575974"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Carotid intima-media thickness (cIMT) is a measure of atherosclerotic vascular disease and a surrogate biomarker for cardiovascular risk in patients with chronic kidney disease (CKD). Mineral and bone disorders (MBD) are complications of CKD, contributing to vascular calcification and accelerated atherosclerosis. Increased fibroblast growth factor 23 (FGF23)\u2014the earliest detectable serum abnormality associated with CKD-MBD\u2014has been linked with cardiovascular disease in patients with CKD. This study aimed to identify factors and analyze the relationship associated with high cIMT, high FGF23, and poor MBD control in children with CKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted in Yogyakarta, Indonesia recruiting children with CKD. The correlations and factors between cIMT, FGF23, and MBD were explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We recruited 42 children aged 2\u201318 years old with CKD stages 2 to 5D. There were no significant correlations between cIMT and factors including advanced CKD, use of dialysis, body mass index, hypertension, anemia, MBD, FGF23 levels, and left ventricular mass index (LVMI). Patients with advanced CKD had poorly controlled anemia, hypertension, and higher LVMI. In multivariate analysis, CKD stages, hypertension stages, the presence of MBD, and LVMI were associated with FGF23 levels (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>FGF23 levels increased with CKD progression, and MBD was more prevalent in advanced kidney disease. Elevated FGF23 is potentially associated with increased MBD prevalence in late-stage CKD. A larger study is needed to confirm the factors affecting cIMT in children with CKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-024-03771-z","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T14:03:19Z","timestamp":1729519399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Carotid intima-media thickness, fibroblast growth factor 23, and mineral bone disorder in children with chronic kidney disease"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8447-8682","authenticated-orcid":false,"given":"Retno","family":"Palupi-Baroto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5069-3867","authenticated-orcid":false,"given":"Kristia","family":"Hermawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9174-8425","authenticated-orcid":false,"given":"Indah Kartika","family":"Murni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7111-8124","authenticated-orcid":false,"given":"Tiara","family":"Nurlita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6628-9500","authenticated-orcid":false,"given":"Yuli","family":"Prihastuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1402-7397","authenticated-orcid":false,"given":"Ira","family":"Puspitawati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8688-8106","authenticated-orcid":false,"given":"Chika Carnation","family":"Tandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0387-1031","authenticated-orcid":false,"given":"Cahyani Gita","family":"Ambarsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"issue":"1","key":"3771_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000470909","volume":"3","author":"M Fukagawa","year":"2017","unstructured":"Fukagawa M, Komaba H. Chronic kidney disease-mineral and bone disorder in Asia. Kidney Dis (Basel). 2017;3(1):1\u20137. https:\/\/doi.org\/10.1159\/000470909.","journal-title":"Kidney Dis (Basel)"},{"issue":"4","key":"3771_CR2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/ckj\/sfw047","volume":"9","author":"F Becherucci","year":"2016","unstructured":"Becherucci F, Roperto RM, Materassi M, Romagnani P. Chronic kidney disease in children. Clin Kidney J. 2016;9(4):583\u201391. https:\/\/doi.org\/10.1093\/ckj\/sfw047.","journal-title":"Clin Kidney J"},{"key":"3771_CR3","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1007\/978-3-030-52719-8_129","volume-title":"Pediatric Nephrology","author":"R Shroff","year":"2002","unstructured":"Shroff R, Wesseling-Perry K, Bacchetta J. Chronic kidney disease \u2013 mineral and bone disorder (CKD-MBD). In: Emma F, Goldstein SL, Bagga A, Bates CM, Shroff R, editors. Pediatric Nephrology. Berlin: Springer; 2002. pp. 1755\u201383. https:\/\/doi.org\/10.1007\/978-3-030-52719-8_129."},{"issue":"10","key":"3771_CR4","doi-asserted-by":"publisher","first-page":"e0205831","DOI":"10.1371\/journal.pone.0205831","volume":"13","author":"ES Andrews","year":"2018","unstructured":"Andrews ES, Perrenoud L, Nowak KL, You Z, Pasch A, Chonchol M, et al. Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; a post-hoc analysis of a randomized clinical trial. PLoS ONE. 2018;13(10):e0205831. https:\/\/doi.org\/10.1371\/journal.pone.0205831.","journal-title":"PLoS ONE"},{"issue":"2","key":"3771_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ekir.2022.10.023","volume":"8","author":"AD Lalayiannis","year":"2022","unstructured":"Lalayiannis AD, Crabtree NJ, Ferro CJ, Wheeler DC, Duncan ND, Smith C, et al. Bone mineral density and vascular calcification in children and young adults with CKD 4 to 5 or on dialysis. Kidney Int Rep. 2022;8(2):265\u201373. https:\/\/doi.org\/10.1016\/j.ekir.2022.10.023.","journal-title":"Kidney Int Rep"},{"key":"3771_CR6","doi-asserted-by":"publisher","first-page":"117954681985294","DOI":"10.1177\/1179546819852941","volume":"13","author":"OM Lawal","year":"2019","unstructured":"Lawal OM, Balogun MO, Akintomide AO, Ayoola OO, Mene-Afejuku TO, Ogunlade O, et al. Carotid intima-media thickness: a surrogate marker for cardiovascular disease in chronic kidney disease patients. Clin Med Insights Cardiol. 2019;13:1179546819852941. https:\/\/doi.org\/10.1177\/1179546819852941.","journal-title":"Clin Med Insights Cardiol"},{"issue":"1","key":"3771_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2215\/CJN.01090216","volume":"12","author":"F Schaefer","year":"2017","unstructured":"Schaefer F, Doyon A, Azukaitis K, Bayazit A, Canpolat N, Duzova A, et al. Cardiovascular phenotypes in children with CKD: the 4\u00a0C study. Clin J Am Soc Nephrol. 2017;12(1):19\u201328. https:\/\/doi.org\/10.2215\/CJN.01090216.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"3771_CR8","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.2215\/CJN.03130312","volume":"7","author":"TM Brady","year":"2012","unstructured":"Brady TM, Schneider MF, Flynn JT, Cox C, Samuels J, Saland J, et al. Carotid intima-media thickness in children with CKD: results from the CKiD study. Clin J Am Soc Nephrol. 2012;7(12):1930\u20137. https:\/\/doi.org\/10.2215\/CJN.03130312.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3771_CR9","doi-asserted-by":"publisher","unstructured":"Lopes R, Morais MB, Oliveira FLC, Brecheret AP, Abreu ALCS, Andrade MC. Evaluation of carotid intima-media thickness and factors associated with cardiovascular disease in children and adolescents with chronic kidney disease. J Pediatr (Rio J). 2019 Nov-Dec;95(6):696\u2013704. https:\/\/doi.org\/10.1016\/j.jped.2018.06.010.","DOI":"10.1016\/j.jped.2018.06.010"},{"issue":"2","key":"3771_CR10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/ki.2010.107","volume":"78","author":"M Husen","year":"2010","unstructured":"Husen M, Fischer A, Lehnhardt A, Klaassen I, Moller K, Muller-Wiefel D, et al. Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease. Kidney Int. 2010;78(2):200\u20136. https:\/\/doi.org\/10.1038\/ki.2010.107.","journal-title":"Kidney Int"},{"issue":"12","key":"3771_CR11","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ki.2011.47","volume":"79","author":"T Isakova","year":"2011","unstructured":"Isakova T, Wahl P, Vargas GS, Guti\u00e9rrez OM, Scialla J, Xie H, et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int. 2011;79(12):1370\u20138. https:\/\/doi.org\/10.1038\/ki.2011.47.","journal-title":"Kidney Int"},{"key":"3771_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2147\/IJNRD.S304143","volume":"14","author":"R Palupi-Baroto","year":"2021","unstructured":"Palupi-Baroto R, Hermawan K, Murni IK, Nurlitasari T, Prihastuti Y, Sekali DRK, et al. High fibroblast growth factor 23 as a biomarker for severe cardiac impairment in children with chronic kidney disease: a single tertiary center study. Int J Nephrol Renovasc Dis. 2021;14:165\u201371. https:\/\/doi.org\/10.2147\/IJNRD.S304143.","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"2","key":"3771_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1681\/ASN.2016090944","volume":"28","author":"T Naveh-Many","year":"2017","unstructured":"Naveh-Many T, Silver J. The pas de trois of vitamin D, FGF23, and PTH. J Am Soc Nephrol. 2017;28(2):393\u20135. https:\/\/doi.org\/10.1681\/ASN.2016090944.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"3771_CR14","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/nrneph.2013.147","volume":"9","author":"J Silver","year":"2013","unstructured":"Silver J, Naveh-Many T. FGF-23 and secondary hyperparathyroidism in chronic kidney disease. Nat Rev Nephrol. 2013;9(11):641\u20139. https:\/\/doi.org\/10.1038\/nrneph.2013.147.","journal-title":"Nat Rev Nephrol"},{"key":"3771_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.33393\/jcb.2022.2328","volume":"11","author":"L Albanese","year":"2022","unstructured":"Albanese L, Caliendo G, D\u2019Elia G, Passariello L, Molinari AM, Napoli C, et al. Diagnostic utility of FGF-23 in mineral bone disorder during chronic kidney disease. J Circ Biomark. 2022;11:1\u20134. https:\/\/doi.org\/10.33393\/jcb.2022.2328.","journal-title":"J Circ Biomark"},{"key":"3771_CR16","doi-asserted-by":"publisher","first-page":"8821292","DOI":"10.1155\/2021\/8821292","volume":"2021","author":"A Kurpas","year":"2021","unstructured":"Kurpas A, Supe\u0142 K, Idzikowska K, Zieli\u0144ska M. FGF23: a review of its role in mineral metabolism and renal and cardiovascular disease. Dis Markers. 2021;2021:8821292. https:\/\/doi.org\/10.1155\/2021\/8821292.","journal-title":"Dis Markers"},{"issue":"2","key":"3771_CR17","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1210\/jc.2008-0326","volume":"94","author":"K Wesseling-Perry","year":"2009","unstructured":"Wesseling-Perry K, Pereira RC, Wang H, Elashoff RM, Sahney S, Gales B, et al. Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. J Clin Endocrinol Metab. 2009;94(2):511\u20137. https:\/\/doi.org\/10.1210\/jc.2008-0326.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"3771_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40348-021-00123-x","volume":"8","author":"M Leifheit-Nestler","year":"2021","unstructured":"Leifheit-Nestler M, Haffner D. How FGF23 shapes multiple organs in chronic kidney disease. Mol Cell Pediatr. 2021;8(1):12. https:\/\/doi.org\/10.1186\/s40348-021-00123-x.","journal-title":"Mol Cell Pediatr"},{"issue":"3","key":"3771_CR19","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s11914-017-0365-0","volume":"15","author":"MR Hanudel","year":"2017","unstructured":"Hanudel MR, Salusky IB. Treatment of pediatric chronic kidney disease-mineral and bone disorder. Curr Osteoporos Rep. 2017;15(3):198\u2013206. https:\/\/doi.org\/10.1007\/s11914-017-0365-0.","journal-title":"Curr Osteoporos Rep"},{"issue":"1","key":"3771_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2215\/CJN.05940611","volume":"7","author":"K Wesseling-Perry","year":"2012","unstructured":"Wesseling-Perry K, Pereira RC, Tseng CH, Elashoff R, Zaritsky JJ, Yadin O, et al. Early skeletal and biochemical alterations in pediatric chronic kidney disease. Clin J Am Soc Nephrol. 2012;7(1):146\u201352. https:\/\/doi.org\/10.2215\/CJN.05940611.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"3771_CR21","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00467-011-1822-0","volume":"26","author":"PR Srivaths","year":"2011","unstructured":"Srivaths PR, Goldstein SL, Silverstein DM, Krishnamurthy R, Brewer ED. Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients. Pediatr Nephrol. 2011;26(6):945\u201351. https:\/\/doi.org\/10.1007\/s00467-011-1822-0.","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"3771_CR22","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s12098-021-03927-x","volume":"89","author":"G Singh","year":"2022","unstructured":"Singh G, Mishra OP, Abhinay A, Agarwal V, Mishra SP, Dwivedi AD, et al. Fibroblast growth factor 23 level and cardiovascular parameters in children with chronic kidney disease. Indian J Pediatr. 2022;89(9):865\u201371. https:\/\/doi.org\/10.1007\/s12098-021-03927-x.","journal-title":"Indian J Pediatr"},{"issue":"9","key":"3771_CR23","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s00467-018-3978-3","volume":"33","author":"E Preka","year":"2018","unstructured":"Preka E, Ranchin B, Doyon A, Vierge M, Ginhoux T, Kassai B, et al. The interplay between bone and vessels in pediatric CKD: lessons from a single-center study. Pediatr Nephrol. 2018;33(9):1565\u201375. https:\/\/doi.org\/10.1007\/s00467-018-3978-3.","journal-title":"Pediatr Nephrol"},{"key":"3771_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.77","volume":"3","author":"KDIGO CKD Work Group","year":"2013","unstructured":"KDIGO CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Supplements. 2013;3:1\u2013150. https:\/\/doi.org\/10.1038\/kisup.2012.77.","journal-title":"Kidney Int Supplements"},{"key":"3771_CR25","unstructured":"KDIGO Executive Committee. KDIGO 2023 clinical practice guideline for the evaluation and management of chronic kidney disease."},{"issue":"3","key":"3771_CR26","doi-asserted-by":"publisher","first-page":"e20171904","DOI":"10.1542\/peds.2017-1904","volume":"140","author":"JT Flynn","year":"2017","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140(3):e20171904. https:\/\/doi.org\/10.1542\/peds.2017-1904.","journal-title":"Pediatrics"},{"issue":"11","key":"3771_CR27","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.2215\/CJN.02110216","volume":"11","author":"AA Portale","year":"2016","unstructured":"Portale AA, Wolf MS, Messinger S, Perwad F, J\u00fcppner H, Warady BA, et al. Fibroblast growth factor 23 and risk of CKD progression in children. Clin J Am Soc Nephrol. 2016;11(11):1989\u201398. https:\/\/doi.org\/10.2215\/CJN.02110216.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"3771_CR28","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.3390\/children9121995","volume":"9","author":"SG Jan\u010di\u010d","year":"2022","unstructured":"Jan\u010di\u010d SG, Mo\u010dnik M, Mar\u010dun Varda N. Glomerular filtration rate assessment in children. Child (Basel). 2022;9(12):1995. https:\/\/doi.org\/10.3390\/children9121995.","journal-title":"Child (Basel)"},{"key":"3771_CR29","doi-asserted-by":"publisher","first-page":"597768","DOI":"10.3389\/fcvm.2020.597768","volume":"7","author":"A Drole Torkar","year":"2020","unstructured":"Drole Torkar A, Plesnik E, Groselj U, Battelino T, Kotnik P. Carotid intima-media thickness in healthy children and adolescents: normative data and systematic literature review. Front Cardiovasc Med. 2020;7:597768. https:\/\/doi.org\/10.3389\/fcvm.2020.597768.","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"3771_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.echo.2007.11.011","volume":"21","author":"JH Stein","year":"2008","unstructured":"Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21(2):93\u2013quiz111189. https:\/\/doi.org\/10.1016\/j.echo.2007.11.011.","journal-title":"J Am Soc Echocardiogr"},{"issue":"4","key":"3771_CR31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.5935\/abc.20160030","volume":"106","author":"LA Baroncini","year":"2016","unstructured":"Baroncini LA, Sylvestre Lde C, Pecoits Filho R. Assessment of intima-media thickness in healthy children aged 1 to 15 years. Arq Bras Cardiol. 2016;106(4):327\u201332. https:\/\/doi.org\/10.5935\/abc.20160030.","journal-title":"Arq Bras Cardiol"},{"issue":"3","key":"3771_CR32","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1161\/HYPERTENSIONAHA.113.01297","volume":"62","author":"A Doyon","year":"2013","unstructured":"Doyon A, Kracht D, Bayazit AK, Deveci M, Duzova A, Krmar RT, et al. Carotid artery intima-media thickness and distensibility in children and adolescents: reference values and role of body dimensions. Hypertension. 2013;62(3):550\u20136. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.01297.","journal-title":"Hypertension"},{"key":"3771_CR33","first-page":"210","volume-title":"Pediatric cardiology for practitioners","author":"MK Park","year":"2016","unstructured":"Park MK, Park. Pediatric cardiology for practitioners. 6th ed. Philadelphia: Elsevier Saunders; 2016. pp. 210\u201323.","edition":"6"},{"issue":"4","key":"3771_CR34","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/kisup.2012.33","volume":"2","author":"KDIGO Anemia Work Group","year":"2012","unstructured":"KDIGO Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Supplements. 2012;2(4):279\u2013335. https:\/\/doi.org\/10.1038\/kisup.2012.33.","journal-title":"Kidney Int Supplements"},{"key":"3771_CR35","unstructured":"World Health Organization. Anaemia [Internet], Geneva. WHO; 2023 [cited on 2023 Nov 17]. https:\/\/www.who.int\/data\/nutrition\/nlis\/info\/anaemia"},{"key":"3771_CR36","doi-asserted-by":"publisher","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009;113S1\u2013130. https:\/\/doi.org\/10.1038\/ki.2009.188.","DOI":"10.1038\/ki.2009.188"},{"issue":"1","key":"3771_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","volume":"7","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group","year":"2017","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2017;7(1):1\u201359. https:\/\/doi.org\/10.1016\/j.kisu.2017.04.001.","journal-title":"Kidney Int Suppl"},{"issue":"4 Suppl 3","key":"3771_CR38","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","volume":"42","author":"National Kidney Foundation","year":"2003","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(4 Suppl 3):S1\u2013201. https:\/\/doi.org\/10.1016\/S0272-6386(03)00905-3.","journal-title":"Am J Kidney Dis"},{"key":"3771_CR39","unstructured":"Mayo Clinic Laboratories. Pediatric catalog: Uric acid, serum [Internet]. Minnesota: Mayo Foundation for Medical Education and Research; 2023 [cited on 2023 Nov 15]. https:\/\/pediatric.testcatalog.org\/show\/URIC"},{"key":"3771_CR40","unstructured":"Centers for Disease Control and Prevention. Defining child BMI categories [Internet]. Atlanta: CDC. 2023 Mar [cited on 2023 Nov 20]. https:\/\/www.cdc.gov\/obesity\/basics\/childhood-defining.html"},{"issue":"9","key":"3771_CR41","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41581-019-0161-4","volume":"15","author":"J Drube","year":"2019","unstructured":"Drube J, Wan M, Bonthuis M, W\u00fchl E, Bacchetta J, Santos F, et al. Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease. Nat Rev Nephrol. 2019;15(9):577\u201389. https:\/\/doi.org\/10.1038\/s41581-019-0161-4.","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"3771_CR42","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.kint.2015.10.014","volume":"89","author":"JR Ingelfinger","year":"2016","unstructured":"Ingelfinger JR, Kalantar-Zadeh K, Schaefer F, World Kidney Day Steering Committee. Averting the legacy of kidney disease\u2013focus on childhood. Kidney Int. 2016;89(3):512\u20138. https:\/\/doi.org\/10.1016\/j.kint.2015.10.014.","journal-title":"Kidney Int"},{"issue":"2","key":"3771_CR43","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/MOP.0b013e32833695cb","volume":"22","author":"M Baum","year":"2010","unstructured":"Baum M. Overview of chronic kidney disease in children. Curr Opin Pediatr. 2010;22(2):158\u201360. https:\/\/doi.org\/10.1097\/MOP.0b013e32833695cb.","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"3771_CR44","doi-asserted-by":"publisher","first-page":"2253324","DOI":"10.1080\/0886022X.2023.2253324","volume":"45","author":"CG Ambarsari","year":"2023","unstructured":"Ambarsari CG, Utami DAP, Tandri CC, Satari HI. Comparison of three spot proteinuria measurements for pediatric nephrotic syndrome: based on the International Pediatric Nephrology Association 2022 guidelines. Ren Fail. 2023;45(2):2253324. https:\/\/doi.org\/10.1080\/0886022X.2023.2253324.","journal-title":"Ren Fail"},{"issue":"10","key":"3771_CR45","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.ekir.2023.07.006","volume":"8","author":"CG Ambarsari","year":"2023","unstructured":"Ambarsari CG, Cho Y, Milanzi E, Francis A, Koh LJ, Lalji R, et al. Epidemiology and outcomes of children with kidney failure receiving kidney replacement therapy in Australia and New Zealand. Kidney Int Rep. 2023;8(10):1951\u201364. https:\/\/doi.org\/10.1016\/j.ekir.2023.07.006.","journal-title":"Kidney Int Rep"},{"issue":"5","key":"3771_CR46","doi-asserted-by":"publisher","first-page":"e047059","DOI":"10.1136\/bmjopen-2020-047059","volume":"11","author":"S Wente-Schulz","year":"2021","unstructured":"Wente-Schulz S, Aksenova M, Awan A, Ambarsari CG, Becherucci F, Emma F, et al. Aetiology, course and treatment of acute tubulointerstitial nephritis in paediatric patients: a cross-sectional web-based survey. BMJ Open. 2021;11(5):e047059. https:\/\/doi.org\/10.1136\/bmjopen-2020-047059.","journal-title":"BMJ Open"},{"issue":"Suppl 2","key":"3771_CR47","first-page":"S103","volume":"71","author":"CG Ambarsari","year":"2021","unstructured":"Ambarsari CG, Tambunan T, Pardede SO, Fazlur Rahman FH, Kadaristiana A. Role of dipstick albuminuria in progression of paediatric chronic kidney disease. J Pak Med Assoc. 2021;71(Suppl 2):S103\u20136.","journal-title":"J Pak Med Assoc"},{"key":"3771_CR48","doi-asserted-by":"publisher","first-page":"3067453","DOI":"10.1155\/2020\/3067453","volume":"2020","author":"CG Ambarsari","year":"2020","unstructured":"Ambarsari CG, Trihono PP, Kadaristiana A, Rachmadi D, Andriastuti M, Puspitasari HA, et al. Low-dose maintenance intravenous iron therapy can prevent anemia in children with end-stage renal disease undergoing chronic hemodialysis. Int J Nephrol. 2020;2020:3067453\u20138. https:\/\/doi.org\/10.1155\/2020\/3067453.","journal-title":"Int J Nephrol"},{"issue":"4","key":"3771_CR49","doi-asserted-by":"publisher","first-page":"192","DOI":"10.14238\/pi51.4.2011.192-7","volume":"51","author":"E Hidayati","year":"2011","unstructured":"Hidayati E, Trihono P. Admission characteristics of pediatric chronic kidney disease. Paediatr Indones. 2011;51(4):192\u20137. https:\/\/doi.org\/10.14238\/pi51.4.2011.192-7.","journal-title":"Paediatr Indones"},{"key":"3771_CR50","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000525776","volume":"12","author":"CG Ambarsari","year":"2022","unstructured":"Ambarsari CG, Saraswati M, Laudza GS. Rituximab, mycophenolic acid, and calcineurin inhibitors achieve long-term remission in pediatric focal segmental glomerulosclerosis with steroid-resistant and frequently relapsing nephrotic syndrome: a report of two cases. Case Rep Nephrol Dial. 2022;12:167\u201377. https:\/\/doi.org\/10.1159\/000525776.","journal-title":"Case Rep Nephrol Dial"},{"key":"3771_CR51","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s12882-022-02874-9","volume":"23","author":"DN Santoso","year":"2022","unstructured":"Santoso DN, Sinuraya FAG, Ambarsari CG. Distal renal tubular acidosis presenting with an acute hypokalemic paralysis in an older child with severe vesicoureteral reflux and syringomyelia: a case report. BMC Nephrol. 2022;23:248. https:\/\/doi.org\/10.1186\/s12882-022-02874-9.","journal-title":"BMC Nephrol"},{"key":"3771_CR52","doi-asserted-by":"publisher","first-page":"329","DOI":"10.13181\/mji.v28i4.3807","volume":"28","author":"CG Ambarsari","year":"2019","unstructured":"Ambarsari CG, Trihono PP, Kadaristiana A, Tambunan T, Mushahar L, Puspitasari HA, et al. Five-year experience of continuous ambulatory peritoneal dialysis in children: a single center experience in a developing country. Med J Indones. 2019;28:329\u201337. https:\/\/doi.org\/10.13181\/mji.v28i4.3807.","journal-title":"Med J Indones"},{"issue":"8","key":"3771_CR53","doi-asserted-by":"publisher","first-page":"e13812","DOI":"10.1111\/petr.13812","volume":"24","author":"CG Ambarsari","year":"2020","unstructured":"Ambarsari CG, Hidayati EL, Trihono PP, Saraswati M, Rodjani A, Wahyudi I, et al. Experience of the first 6 years of pediatric kidney transplantation in Indonesia: a multicenter retrospective study. Pediatr Transpl. 2020;24(8):e13812. https:\/\/doi.org\/10.1111\/petr.13812.","journal-title":"Pediatr Transpl"},{"issue":"19","key":"3771_CR54","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","volume":"119","author":"OM Guti\u00e9rrez","year":"2009","unstructured":"Guti\u00e9rrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G, et al. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation. 2009;119(19):2545\u201352. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.844506.","journal-title":"Circulation"},{"issue":"5","key":"3771_CR55","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1161\/HYPERTENSIONAHA.117.08770","volume":"69","author":"L Voroneanu","year":"2017","unstructured":"Voroneanu L, Covic A. Vascular damage in children with chronic kidney disease: the fog is dispersing. Hypertension. 2017;69(5):791\u20134. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.08770.","journal-title":"Hypertension"},{"issue":"9","key":"3771_CR56","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.7863\/jum.2008.27.9.1353","volume":"27","author":"F Faita","year":"2008","unstructured":"Faita F, Gemignani V, Bianchini E, Giannarelli C, Ghiadoni L, Demi M. Real-time measurement system for evaluation of the carotid intima-media thickness with a robust edge operator. J Ultrasound Med. 2008;27(9):1353\u201361. https:\/\/doi.org\/10.7863\/jum.2008.27.9.1353.","journal-title":"J Ultrasound Med"},{"issue":"5","key":"3771_CR57","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11883-011-0200-5","volume":"13","author":"EY Yang","year":"2011","unstructured":"Yang EY, Nambi V. Ultrasound imaging of carotid intima-media thickness: an office-based tool to assist physicians in cardiovascular risk assessment. Curr Atheroscler Rep. 2011;13(5):431\u20136. https:\/\/doi.org\/10.1007\/s11883-011-0200-5.","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"3771_CR58","doi-asserted-by":"publisher","first-page":"38","DOI":"10.5853\/jos.2013.15.1.38","volume":"15","author":"SA Peters","year":"2013","unstructured":"Peters SA, Bots ML. Carotid intima-media thickness studies: study design and data analysis. J Stroke. 2013;15(1):38\u201348. https:\/\/doi.org\/10.5853\/jos.2013.15.1.38.","journal-title":"J Stroke"},{"issue":"3","key":"3771_CR59","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3390\/life11030204","volume":"11","author":"A Rizikalo","year":"2021","unstructured":"Rizikalo A, Coric S, Matetic A, Vasilj M, Tocilj Z, Bozic J. Association of glomerular filtration rate and carotid intima-media thickness in non-diabetic chronic kidney disease patients over a 4-year follow-up. life (Basel). 2021;11(3):204. https:\/\/doi.org\/10.3390\/life11030204.","journal-title":"life (Basel)"},{"issue":"2","key":"3771_CR60","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2215\/CJN.05840513","volume":"9","author":"AA Portale","year":"2014","unstructured":"Portale AA, Wolf M, J\u00fcppner H, Messinger S, Kumar J, Wesseling-Perry K, et al. Disordered FGF23 and mineral metabolism in children with CKD. Clin J Am Soc Nephrol. 2014;9(2):344\u201353. https:\/\/doi.org\/10.2215\/CJN.05840513.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"3771_CR61","doi-asserted-by":"publisher","first-page":"e0201537","DOI":"10.1371\/journal.pone.0201537","volume":"13","author":"C Rodelo-Haad","year":"2018","unstructured":"Rodelo-Haad C, Rodriguez-Ortiz ME, Martin-Malo A, Mier MV, Aguera ML, Munoz-Castaneda JR, et al. Phosphate control in reducing FGF23 levels in hemodialysis patients. PLoS ONE. 2018;13(8):e0201537. https:\/\/doi.org\/10.1371\/journal.pone.0201537.","journal-title":"PLoS ONE"},{"key":"3771_CR62","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1007\/s00467-012-2224-7","volume":"27","author":"W Seeherunvong","year":"2012","unstructured":"Seeherunvong W, Abithol CL, Chandar J, Rusconi P, Zilleruelo GE, Freundlich M. Fibroblast growth factor 23 and left ventricular hypertrophy in children on dialysis. Pediatr Nephrol. 2012;27:2129\u201336. https:\/\/doi.org\/10.1007\/s00467-012-2224-7.","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"3771_CR63","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1210\/jc.2009-1576","volume":"95","author":"J Bacchetta","year":"2010","unstructured":"Bacchetta J, Dubourg L, Harambat J, Ranchin B, Abou-Jaoude P, Arnaud S, et al. The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease. J Clin Endocrinol Metab. 2010;95(4):1741\u20138. https:\/\/doi.org\/10.1210\/jc.2009-1576.","journal-title":"J Clin Endocrinol Metab"},{"key":"3771_CR64","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2147\/IJNRD.S191156","volume":"12","author":"B Waziri","year":"2019","unstructured":"Waziri B, Duarte R, Naicker S. Chronic kidney disease-mineral and bone disorder (CKD-MBD): current perspectives. Int J Nephrol Renovasc Dis. 2019;12:263\u201376. https:\/\/doi.org\/10.2147\/IJNRD.S191156.","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"3771_CR65","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1152\/ajprenal.00633.2013","volume":"306","author":"SY Yamada","year":"2014","unstructured":"Yamada SY, Tokumoto M, Tatsumoto N, Taniguchi M, Noguchi H, Nakano T, et al. Phosphate overload directly induces systemic inflammation and malnutrition as well as vascular calcification in uremia. Am J Physiol Ren Physiol. 2014;306:1418\u201328. https:\/\/doi.org\/10.1152\/ajprenal.00633.2013.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"2","key":"3771_CR66","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.kint.2018.02.026","volume":"94","author":"K Durlacher-Betzer","year":"2018","unstructured":"Durlacher-Betzer K, Hassan A, Levi R, Axelrod J, Silver J, Naveh-Many T. Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease. Kidney Int. 2018;94(2):315\u201325. https:\/\/doi.org\/10.1016\/j.kint.2018.02.026.","journal-title":"Kidney Int"},{"key":"3771_CR67","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000504043","volume":"9","author":"CG Ambarsari","year":"2019","unstructured":"Ambarsari CG, Sindih RM, Saraswati M, Trihono PP. Delayed admission and management of pediatric acute kidney injury and multiple organ dysfunction syndrome in children with multiple wasp stings: a case series. Case Rep Nephrol Dial. 2019;9:137\u201348. https:\/\/doi.org\/10.1159\/000504043.","journal-title":"Case Rep Nephrol Dial"},{"issue":"5","key":"3771_CR68","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00109-021-02036-8","volume":"99","author":"M Feger","year":"2021","unstructured":"Feger M, Ewendt F, Strotmann J, Sch\u00e4ffler H, Kempe-Teufel D, Glosse P, et al. Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23). J Mol Med (Berl). 2021;99(5):699\u2013711. https:\/\/doi.org\/10.1007\/s00109-021-02036-8.","journal-title":"J Mol Med (Berl)"},{"issue":"2","key":"3771_CR69","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3892\/etm.2023.12089","volume":"26","author":"D Liu","year":"2023","unstructured":"Liu D, Yang F, Zhang S, Guo Z, Peng S. Significance of changes in FGF23 levels in childhood primary nephrotic syndrome and children who progress to endstage renal disease. Exp Ther Med. 2023;26(2):390. https:\/\/doi.org\/10.3892\/etm.2023.12089.","journal-title":"Exp Ther Med"},{"issue":"9","key":"3771_CR70","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1007\/s11255-017-1605-z","volume":"49","author":"S Bi","year":"2017","unstructured":"Bi S, Liang Y, Cheng L, Wang Y, Wang T, Han Q, et al. Hemodialysis is associated with higher serum FGF23 level when compared with peritoneal dialysis. Int Urol Nephrol. 2017;49(9):1653\u20139. https:\/\/doi.org\/10.1007\/s11255-017-1605-z.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"3771_CR71","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/0886022X.2020.1713805","volume":"42","author":"CG Ambarsari","year":"2020","unstructured":"Ambarsari CG, Cahyadi D, Sari L, Satria O, Sahli F, Darmadi TL, et al. Late diagnosis of Lesch-Nyhan disease complicated with end-stage renal disease and tophi disease and tophi burst. Ren Fail. 2020;42(1):113\u201321. https:\/\/doi.org\/10.1080\/0886022X.2020.1713805.","journal-title":"Ren Fail"},{"issue":"1","key":"3771_CR72","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/medicina57010015","volume":"57","author":"A Balmukhanova","year":"2020","unstructured":"Balmukhanova A, Kabulbayev K, Alpay H, Kanatbayeva A, Balmukhanova A. FGF-23 and phosphate in children with chronic kidney disease: a cross-sectional study in Kazakhstan. Med (Kaunas). 2020;57(1):15. https:\/\/doi.org\/10.3390\/medicina57010015.","journal-title":"Med (Kaunas)"},{"issue":"12","key":"3771_CR73","first-page":"2261","volume":"15","author":"AH Guo","year":"2011","unstructured":"Guo AH, Meng JZ, Li DD, Liu WY, Wang SX, Gao F, et al. Adsorptive dialysis for cleaning uremic middle molecular substances. J Clin Rehabil Tissue Eng Res. 2011;15(12):2261\u20134.","journal-title":"J Clin Rehabil Tissue Eng Res"},{"issue":"3","key":"3771_CR74","doi-asserted-by":"publisher","first-page":"290","DOI":"10.13181\/mji.oa.204171","volume":"29","author":"CG Ambarsari","year":"2020","unstructured":"Ambarsari CG, Hidayati EL, Mushahar L, Kadaristiana A. Dressing versus non-dressing technique for long-term exit-site care in children on continuous ambulatory peritoneal dialysis: a single-center retrospective cohort study. Med J Indones. 2020;29(3):290\u20137. https:\/\/doi.org\/10.13181\/mji.oa.204171.","journal-title":"Med J Indones"},{"key":"3771_CR75","unstructured":"Hac\u0131hamdio\u011flu D\u00d6, D\u00fczova A, Alehan D, O\u011fuz B, Be\u015fba\u015f N. Circulating fibroblast growth factor 23 in children on peritoneal dialysis is associated with effective dialysis. Turk J Pediatr. 2015 Jan-Feb;57(1):9\u201316. PMID : 26613215."},{"issue":"11","key":"3771_CR76","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.2215\/CJN.04290511","volume":"6","author":"T Isakova","year":"2011","unstructured":"Isakova T, Xie H, Barchi-Chung A, Vargas G, Sowden N, Houston J, et al. Fibroblast growth factor 23 in patients undergoing peritoneal dialysis. Clin J Am Soc Nephrol. 2011;6(11):2688\u201395. https:\/\/doi.org\/10.2215\/CJN.04290511.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"3771_CR77","doi-asserted-by":"publisher","first-page":"CD006515","DOI":"10.1002\/14651858.CD006515","volume":"2007","author":"KS Rabindranath","year":"2007","unstructured":"Rabindranath KS, Adams J, Ali TZ, MacLeod AM, Vale L, Cody J, et al. Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease. Cochrane Database Syst Rev. 2007;2007(2):CD006515. https:\/\/doi.org\/10.1002\/14651858.CD006515.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"3771_CR78","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s11255-020-02678-6","volume":"53","author":"A Roumeliotis","year":"2021","unstructured":"Roumeliotis A, Roumeliotis S, Leivaditis K, Salmas M, Eleftheriadis T, Liakopoulos V. APD or CAPD: one glove does not fit all. Int Urol Nephrol. 2021;53(6):1149\u201360. https:\/\/doi.org\/10.1007\/s11255-020-02678-6.","journal-title":"Int Urol Nephrol"},{"issue":"10","key":"3771_CR79","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.3390\/nu14102124","volume":"14","author":"M Haarhaus","year":"2022","unstructured":"Haarhaus M, Cianciolo G, Barbuto S, La Manna G, Gasperoni L, Tripepi G, et al. Alkaline phosphatase: an old friend as treatment target for cardiovascular and mineral bone disorders in chronic kidney disease. Nutrients. 2022;14(10):2124. https:\/\/doi.org\/10.3390\/nu14102124.","journal-title":"Nutrients"},{"issue":"7","key":"3771_CR80","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s00467-020-04499-2","volume":"35","author":"EMD Soeiro","year":"2020","unstructured":"Soeiro EMD, Castro L, Menezes R, Elias RM, Dos Reis LM, Jorgetti V, et al. Association of parathormone and alkaline phosphatase with bone turnover and mineralization in children with CKD on dialysis: effect of age, gender, and race. Pediatr Nephrol. 2020;35(7):1297\u2013305. https:\/\/doi.org\/10.1007\/s00467-020-04499-2.","journal-title":"Pediatr Nephrol"},{"key":"3771_CR81","doi-asserted-by":"publisher","unstructured":"Lamb EJ, Delaney MP. Does PTH offer additive value to ALP measurement in assessing CKD-MBD? Perit Dial Int. 2014 Nov-Dec;34(7):687\u201391. https:\/\/doi.org\/10.3747\/pdi.2014.00246","DOI":"10.3747\/pdi.2014.00246"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03771-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03771-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03771-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T14:04:40Z","timestamp":1729519480000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03771-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3771"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03771-z","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,21]]},"assertion":[{"value":"15 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the Institutional Review Board of Dr. Sardjito General Hospital and the Medical and Health Research Ethics Committee of the Faculty of Medicine, Public Health, and Nursing at Universitas Gadjah Mada (Approval number: (KE\/FK\/1251\/EC\/2018)) and adhered to the principles of the Declaration of Helsinki. All patients\u2019 caregivers provided written informed consent. This study is not a clinical trial study, therefore it does not have a Clinical Trial Number.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"369"}}